Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients

Journal of Infection

Volumn 50, Issue 2, 2005, Pages 130-137

  Bonon, Sandra H A ^a   Menoni, Silvia M F ^a   Rossi, Cláudio L ^a   De Souza, Cármino A ^a   Vigorito, Afonso C ^a   Costa, Daniel B ^b   Costa, Sandra C B ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Cytomegalovirus infection; PCR

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; GANCICLOVIR; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CAUSE OF DEATH; CHILD; CHRONIC GRANULOCYTIC LEUKEMIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS INFECTION; FEMALE; HEALTH SURVEY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; VIRAL MATRIX PROTEINS;

EID: 12444343092     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2003.11.010     Document Type: Article

References (40)

1. Forman A.J. Zaia J.A. Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: Where do we stand? Blood 83 1994 2392-2398
2. Reusser P. The challenge of cytomegalovirus infection after bone marrow tPansplantation: Epidemiology: prophylaxis, and therapy Bone Marrow Transplant 18 Suppl. 2 1996 107-109
3. Goodrich J.M. Mori M. Gleaves C.A. et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation N Engl J Med 235 23 1991 1601-1607
4. Winston D.J. Winston G.H. Kathy Bartony R.N. et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients Ann Intern Med 118 1993 179-184
5. Goodrich J.M. Bowden R.A. Fisher L. et al. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant Ann Intern Med 118 1993 173-178
6. Costa S.C.B. Miranda S.R.P. Alves G. et al. Detection of cytomegalovirus infections by PCR in renal transplant patients Braz J Med Biol Res 32 1999 953-959
7. Zaia J.A. Cytomegalovirus infections Thomas E.D. Blume K.G. Forman S.J. Hematopoietic cell transplantation 2nd ed 1999 560-583 Blackwell Science Oxford
8. Boeckh M. Boivin G. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications Clin Microbiol Rev 11 3 1998 533-554
9. Shibata D. Martin W.J. Appleman M.D. et al. Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus J Infect Dis 158 1988 1185-1192
10. Boeckh M. Bowden R. Goodrich J.M. et al. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation Blood 80 1992 1358-1364
11. Gondo H. Minematsu T. Harada M. et al. Cytomegalovirus (CMV) antigenaemia for a rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation Br J Haematol 86 1 1994 130-137
12. Przepiorka D. Weisdorf D. Martin P. et al. Consensus conference on acute GVHD grading Bone Marrow Transplant 15 1995 825-828
13. Van der Bij W. Schirm J. Torensma R. Van Son W.J. et al. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood J Clin Microbiol 26 12 1988 2531-2535
14. Halwachs G. Zach R. Pogglitsch H. Holzer H. et al. A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice Transplantation 56 2 1993 338-342
15. Pannuti C.S. Kallás E.G. Muccioli C. Roland R.K. et al. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis Am J Ophthalmol 122 6 1996 847-852
16. Demmler G.J. Buffone G.J. Schimbor C.M. et al. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification J Infect Dis 158 1988 1177-1184
17. Ljungman P. Plotkin S.A. Workshop on CMV disease; definition, clinical severity scores, and new syndromes Scand J Infect Dis 99 1995 87-89
18. Azevedo A.M. Torquato J.P. Vigorito A.C. et al. Prophylaxis of cytomegalovirus infection with low-dose intravenous ganciclovir in allogeneic bone marrow transplant patients Br J Haematol 93 Suppl. 2 1996 250
19. Kaplan E.D. Meier P. Non-parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457-481
20. Altman D.G. Practical statistics for medical research 14 1991 Chapman and Hall London
21. Chakrabarti S. Mackinnon S. Chopra R. et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: Potential role of Campath-1H in delaying immune reconstitution Blood 99 2002 4357-4363
22. Yakushiji K. Gondo H. Kamezaki K. et al. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: Comparison of an antigenemia assay and quantitative real-time polymerase chain reaction Bone Marrow Transplant 29 2002 599-606
23. Machado C.M. Dulley F.L. Vilas Boas L.S. et al. CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy Bone Marrow Transplant 26 2000 413-417
24. Li C.R. Geenberg P.D. Gilbert M.J. et al. HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis Blood 83 1994 1971-1979
25. Stocchi R. Szydlo R. Craddock C. et al. A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation Bone Marrow Transplant 23 1999 705-709
26. Boeckh M. Leisenring W. Riddell S.R. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity Blood 101 2003 407-414
27. Hebart H. Müller C. Löffler J. et al. Monitoring of CMV infection: A comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation Bone Marrow Transplant 17 1996 861-868
28. Machado C.M. Menezes R.X. Macedo M.C.A. et al. Extended antigenemia surveillance and late cytomegalovirus infection after allogeneic BMT Bone Marrow Transplant 28 2001 1053-1059
29. Manteiga R. Martino R. Sureda A. et al. Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: A single-center experience Bone Marrow Transplant 22 1998 89-904
30. Mori T. Okamoto S. Matsuoka S. et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation Bone Marrow Transplant 25 2000 765-769
31. Boeckh M. Gooley T.A. Myerson D. et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study Blood 88 1996 4063-4071
32. Razonable R.R. Brown R.A. Wilson J. et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease Transplantation 73 2002 968-973
33. Gor D. Sabin C. Prentice H.G. et al. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease Bone Marrow Transplant 21 1998 597-605
34. Gerna G. Baldanti F. Lilleri D. et al. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for pre-emptive therapy in bone marrow transplant recipients J Clin Microbiol 38 2000 1845-1853
35. Hebart H. Wuchter P. Loccr J. et al. Evaluation of the Murex CMV DNA hybrid capture assay version 2.0 for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplant Bone Marrow Transplant 28 2001 213-218
36. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients Br J Haematol 118 2002 44-57
37. Peggs K.S. Preiser W. Panagiotis D. et al. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation Br J Haematol 111 2000 782-790
38. Humar A. Lipton J. Welsh S. et al. A randomized trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients Bone Marrow Transplant 28 2001 485-490
39. Eid K. Miranda E. Vigorito A. et al. Critical analysis concerning the availability of full match sibling donors and feasibility of allogeneic bone marrow transplantation in Brazil Bone Marrow Transplant 29 Suppl. 2 2002 S238
40. Einsele H. Hebart H. Kauffmann-Schneider C. et al. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection Bone Marrow Transplant 25 2000 757-763